Article Details
Retrieved on: 2024-06-07 14:39:25
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
They were treated with the monoclonal antibodies Opdivo (nivolumab) and Yervoy (ipilimumab). At the time of surgery, 95% of patients had 10% or ...
Article found on: www.forbes.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here